IE812147L - Combination compositions - Google Patents
Combination compositionsInfo
- Publication number
- IE812147L IE812147L IE812147A IE214781A IE812147L IE 812147 L IE812147 L IE 812147L IE 812147 A IE812147 A IE 812147A IE 214781 A IE214781 A IE 214781A IE 812147 L IE812147 L IE 812147L
- Authority
- IE
- Ireland
- Prior art keywords
- antibiotic
- amino
- physiologically acceptable
- combination compositions
- combination
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Pharmaceutical compositions comprising, in combination, an antibiotic or a physiologically acceptable salt thereof and trans-4-[(2-amino-3,5- dibromo-benzyl)-amino]cyclohexanol or a physiologically acceptable acid addition salt thereof (e.g. the hydrochloride, ambroxol), optionally in association with a pharmaceutical carrier or excipient for use in combating bacterial infections of the respiratory tract. The antibiotic is preferably erythromycin, doxycycline, oxytetracycline, chloramphenicol, cephalexin, ampicillin or amoxycillin.
[GB2083749A]
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3034975A DE3034975C2 (en) | 1980-09-17 | 1980-09-17 | Drug combination used to treat infectious respiratory diseases |
Publications (2)
Publication Number | Publication Date |
---|---|
IE812147L true IE812147L (en) | 1982-03-17 |
IE51517B1 IE51517B1 (en) | 1987-01-07 |
Family
ID=6112126
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IE2147/81A IE51517B1 (en) | 1980-09-17 | 1981-09-16 | Drug combination for the treatment of infectious diseases of the respiratory tract |
Country Status (8)
Country | Link |
---|---|
CH (1) | CH648209A5 (en) |
DE (1) | DE3034975C2 (en) |
FR (1) | FR2493145A1 (en) |
GB (1) | GB2083749B (en) |
HK (1) | HK20785A (en) |
IE (1) | IE51517B1 (en) |
SG (1) | SG785G (en) |
ZA (1) | ZA816417B (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5888311A (en) * | 1981-11-20 | 1983-05-26 | Teijin Ltd | Remedy for respiratory disease |
AUPN115095A0 (en) * | 1995-02-15 | 1995-03-09 | Butt, Henry Lawrence | Analysis of and compositions and methods for the treatment of disease |
DE19933148A1 (en) * | 1999-07-20 | 2001-01-25 | Boehringer Ingelheim Int | Lozenge containing ambroxol |
US20030166732A1 (en) * | 2002-02-27 | 2003-09-04 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Ambroxol for the treatment of painful conditions in the mouth and pharyngeal cavity |
CN1323662C (en) * | 2004-06-18 | 2007-07-04 | 江苏恒瑞医药股份有限公司 | Pharmaceutical composition containing ambroxol and erdosteine or acetylcysteine and application thereof |
CN100434078C (en) * | 2005-05-16 | 2008-11-19 | 天津药物研究院 | Ambroxol hydrochloride compound slow-release tablet and its preparing method |
RU2749902C2 (en) * | 2018-10-31 | 2021-06-18 | Общество С Ограниченной Ответственностью "Валента-Интеллект" | Pharmaceutical composition for treatment of infectious and inflammatory diseases |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE795585A (en) * | 1972-02-17 | 1973-08-16 | Thomae Gmbh Dr K | NEW PULMONARY MEDICINE |
-
1980
- 1980-09-17 DE DE3034975A patent/DE3034975C2/en not_active Expired
-
1981
- 1981-09-15 CH CH5962/81A patent/CH648209A5/en not_active IP Right Cessation
- 1981-09-16 ZA ZA816417A patent/ZA816417B/en unknown
- 1981-09-16 GB GB8127983A patent/GB2083749B/en not_active Expired
- 1981-09-16 IE IE2147/81A patent/IE51517B1/en not_active IP Right Cessation
- 1981-09-17 FR FR8117603A patent/FR2493145A1/en active Granted
-
1985
- 1985-01-04 SG SG7/85A patent/SG785G/en unknown
- 1985-03-21 HK HK207/85A patent/HK20785A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
GB2083749A (en) | 1982-03-31 |
SG785G (en) | 1985-06-14 |
FR2493145A1 (en) | 1982-05-07 |
ZA816417B (en) | 1983-05-25 |
GB2083749B (en) | 1984-05-23 |
DE3034975C2 (en) | 1986-11-27 |
FR2493145B1 (en) | 1984-12-21 |
DE3034975A1 (en) | 1982-04-29 |
HK20785A (en) | 1985-03-29 |
CH648209A5 (en) | 1985-03-15 |
IE51517B1 (en) | 1987-01-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1452172A3 (en) | Multiple unit pharmaceutical preparation | |
CA2123909A1 (en) | New combination of formoterol and budesonide | |
MA23170A1 (en) | PROCESS FOR THE PREPARATION OF A NEW COMPOUND. | |
CA2360248A1 (en) | Combinations of formoterol and a tiotropium salt | |
EP0978276A3 (en) | Polymer coated tablet comprising amoxycillin and clavunalate | |
DE59009074D1 (en) | Diaryl-substituted heterocyclic compound, its preparation and pharmaceuticals and cosmetics made therefrom. | |
EP0160501A3 (en) | Sustained release intranasal formulation and method of use thereof | |
IE812147L (en) | Combination compositions | |
CA2069608A1 (en) | Substituted 4-phenyl-4-piperidinecarboxamides with both local anaesthetic and analgesic effect as well as processes for their preparation | |
GR3031542T3 (en) | Cephalosporinderivatives and process for its preparation | |
DE69202696D1 (en) | Medicament containing ranitidine / bismuth carboxylate salts. | |
EP0137442A3 (en) | Cephalosporin derivatives and process for their preparation | |
IE880503L (en) | Crystallized cephem-acid addition salts, and a process for the preparation thereof | |
DK211489A (en) | PHARMACEUTICAL PREPARATION | |
EP1074554A3 (en) | 7-acyl-3-(substituted carbamoyloxy) cephem compounds, use thereof and process for their preparation | |
JPS57146723A (en) | Pharmaceutical preparation having improved absorption | |
IL108246A (en) | (all-e)-3,7-dimethyl-9-(3, 5-dimethyl- 2-nonyloxyphenyl)-2, 4, 6, 8-nonatetraenoic acid derivatives, their preparation and pharmaceutical compositions containing them | |
IE37288B1 (en) | Pharmaceutical compositions for use in the treatment of certain respiratory diseases or conditions in prematurely born children | |
IE43848L (en) | Pharmaceutical compositions | |
ES2002903A6 (en) | Cephalosporin derivatives and process for their preparation. | |
GB9323404D0 (en) | Pharmaceuticals | |
ZA828127B (en) | Pyridazinone-imines and their physiologically tolerated acid addition salts, their preparation, and therapeutic agents containing these compounds | |
CA2013226A1 (en) | Cephalosporin derivatives and processes for their preparation | |
IE901180L (en) | Polar cephalosporin derivatives and a process for the¹preparation thereof | |
JO1881B1 (en) | Multiple unit tableted dosage from ii |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK9A | Patent expired |